10-29289211-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000375500.8(LYZL1):āc.94A>Gā(p.Thr32Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000503 in 1,590,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
ENST00000375500.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LYZL1 | NM_032517.6 | c.-45A>G | 5_prime_UTR_variant | 1/5 | ENST00000649382.2 | NP_115906.4 | ||
LYZL1 | XM_005252627.4 | c.94A>G | p.Thr32Ala | missense_variant | 1/5 | XP_005252684.1 | ||
LYZL1 | XM_017016791.2 | c.94A>G | p.Thr32Ala | missense_variant | 1/5 | XP_016872280.1 | ||
LYZL1 | XR_428650.2 | n.142A>G | non_coding_transcript_exon_variant | 1/6 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000680 AC: 1AN: 146988Hom.: 0 Cov.: 23
GnomAD4 exome AF: 0.00000485 AC: 7AN: 1443106Hom.: 0 Cov.: 35 AF XY: 0.00000279 AC XY: 2AN XY: 717854
GnomAD4 genome AF: 0.00000680 AC: 1AN: 146988Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 71442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 04, 2024 | The c.94A>G (p.T32A) alteration is located in exon 1 (coding exon 1) of the LYZL1 gene. This alteration results from a A to G substitution at nucleotide position 94, causing the threonine (T) at amino acid position 32 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at